The GLP-1 receptor agonists, exenatide and liraglutide, mimic the action of endogenous GLP-1
No matter your insurance situation, Ro offers support and treatment options to help you move forward
Before travelling abroad with retatrutide, you should: Research the destination country's regulations regarding the importation of prescription and investigational medicines contact the relevant embassy or national medicines agency for guidance Carry a detailed letter from your prescribing clinician in both English and, where possible, the language of your destination country Declare the medication at customs if required failure to declare prescription medicines can result in confiscation or legal penalties in some countries Check whether the medication is classified as a controlled substance in your destination, as some peptide-based compounds face stricter controls internationally If you are a clinical trial participant , obtain explicit approval and documentation from your trial sponsor before transporting retatrutide across international borders, as export and import restrictions may apply The UK Foreign, Commonwealth & Development Office (FCDO) provides country-specific travel health and medication guidance
Some desire quicker outcomes, some desire metabolic endurance or more energy in addition to just appearance, and knowing motivations provides realistic expectations
